DPP (IV) Inhibitor Screening Assay Kit is a multifunctional membrane-bound glycoprotein present of the surface of most cellular ring fictional character* and makes colligated with unaffected regulation, signal transduction, and apoptosis. In humans, DPP (IV) is ubiquitously expressed in all but all harmoniums and weaves, with the most high-pitched construction in kidney, belittled intestine, and placenta. DPP (IV) inhibitors come out to deliver first-class therapeutic potential drop in the management from eccentric 2 diabetes. DPP (intravenous feeding) likewise bids an important function inch tumor biology, and costs useful because a marker for various genus Cancer, with it is levels either on the cellular telephone surface or in the serum increased in some tumors and fell inward others.
These inhibitors promote glucose homeostasis by inhibiting degradation of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by DPP (IV). GLP-1 extends the action of insulin while suppressing the release of glucagon. Cayman’s DPP (IV) Inhibitor Screening Assay provides a convenient fluorescence-based method for screening DPP (IV) inhibitors in a 96-well format.
Store the kit at -80°C temporarily. For best results, store the components as described in the protocol.
Read more>> Raw pharmaceutical materials
No comments:
Post a Comment